Cargando…

The identification and functional analysis of CD8+PD-1+CD161+ T cells in hepatocellular carcinoma

Immunotherapy is a powerful therapeutic strategy for end-stage hepatocellular carcinoma (HCC). It is well known that T cells, including CD8+PD-1+ T cells, play important roles involving tumor development. However, their underlying phenotypic and functional differences of T cell subsets remain unclea...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Zhixuan, Zheng, Bo, Qiu, Xinyao, Wu, Rui, Wu, Tong, Yang, Shuai, Zhu, Yanjing, Wu, Xuan, Wang, Shan, Gu, Ziqi, Shen, Siyun, Wu, Mengchao, Wang, Hongyang, Chen, Lei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7599220/ https://www.ncbi.nlm.nih.gov/pubmed/33145436 http://dx.doi.org/10.1038/s41698-020-00133-4

Ejemplares similares

Trajectory and Functional Analysis of PD‐1(high) CD4(+)CD8(+) T Cells in Hepatocellular Carcinoma by Single‐Cell Cytometry and Transcriptome Sequencing
por: Zheng, Bo, et al.
Publicado: (2020)

Percentages of CD4+CD161+ and CD4−CD8−CD161+ T Cells in the Synovial Fluid Are Correlated with Disease Activity in Rheumatoid Arthritis
por: Miao, Jinlin, et al.
Publicado: (2015)

Cytotoxic CD161(−)CD8(+) T(EMRA) cells contribute to the pathogenesis of systemic lupus erythematosus
por: Xiong, Hui, et al.
Publicado: (2023)

Identification of Cytolytic CD161(−)CD56(+) Regulatory CD8 T Cells in Human Peripheral Blood
por: Hu, Dan, et al.
Publicado: (2013)

CD8(+)CD161(+) T-Cells: Cytotoxic Memory Cells With High Therapeutic Potential
por: Konduri, Vanaja, et al.
Publicado: (2021)

Loss of Circulating CD8+ CD161(high) T Cells in Primary Progressive Multiple Sclerosis
por: Acquaviva, Massimo, et al.
Publicado: (2019)

CD161-Expressing Human T Cells
por: Fergusson, Joannah R., et al.
Publicado: (2011)

Association Between Impaired Vα7.2+CD161++CD8+ (MAIT) and Vα7.2+CD161-CD8+ T-Cell Populations and Gut Dysbiosis in Chronically HIV- and/or HCV-Infected Patients
por: Merlini, Esther, et al.
Publicado: (2019)

Comprehensive analysis of spatial architecture in primary liver cancer
por: Wu, Rui, et al.
Publicado: (2021)

CD161(int) CD8+ T cells: a novel population of highly functional, memory CD8+ T cells enriched within the gut
por: Fergusson, J.R., et al.
Publicado: (2015)

CD161+ regulatory t cells in immune regulation
por: Duurland, Chantal, et al.
Publicado: (2014)

Sulfated polymannuroguluronate TGC161 ameliorates leukopenia by inhibiting CD4(+) T cell apoptosis
por: Shi, Chuanqin, et al.
Publicado: (2020)

Variable density of CD8+ and CD25+ programmed cell death-1 (PD-1) ligand (PD-L1) CD4+ T cells within the tumor microenvironment causes differential responses to the PD-1/PD-L1 blockade
por: Wu, Si-Pei, et al.
Publicado: (2015)

Enhanced Th1/Th17 Functions of CD161(+) CD8(+) T Cells in Mucosal Tissues of Rhesus Macaques
por: Rout, Namita
Publicado: (2016)

CD161(+) Tconv and CD161(+) Treg Share a Transcriptional and Functional Phenotype despite Limited Overlap in TCRβ Repertoire
por: Duurland, Chantal L., et al.
Publicado: (2017)

A Pan-Cancer Analysis of CD161, a Potential New Immune Checkpoint
por: Zhou, Xiaohan, et al.
Publicado: (2021)

Age and CD161 Expression Contribute to Inter-Individual Variation in Interleukin-23 Response in CD8+ Memory Human T Cells
por: Shen, Hui, et al.
Publicado: (2013)

Clinical characterization and immunosuppressive regulation of CD161 (KLRB1) in glioma through 916 samples
por: Di, Wang, et al.
Publicado: (2021)

Hepatobiliary Tumor Organoids Reveal HLA Class I Neoantigen Landscape and Antitumoral Activity of Neoantigen Peptide Enhanced with Immune Checkpoint Inhibitors
por: Wang, Wenwen, et al.
Publicado: (2022)

Comparative expression analysis of PD-1, PD-L1, and CD8A in lung adenocarcinoma
por: Ma, Ke, et al.
Publicado: (2020)

Airway CD8(+)CD161(++)TCRvα7.2(+) T Cell Depletion During Untreated HIV Infection Targets CD103 Expressing Cells
por: Mvaya, Leonard, et al.
Publicado: (2019)

The Predictive Value of CD3+/CD8+ Lymphocyte Infiltration and PD-L1 Expression in Colorectal Cancer
por: Liu, Jihong, et al.
Publicado: (2023)

Uncovering PD-L1 and CD8(+) TILS Expression and Clinical Implication in Cervical Squamous Cell Carcinoma
por: Chen, Jingjing, et al.
Publicado: (2020)

Intestinal Permeability and Circulating CD161+CCR6+CD8+T Cells in Patients With Relapsing–Remitting Multiple Sclerosis Treated With Dimethylfumarate
por: Buscarinu, Maria C., et al.
Publicado: (2021)

LLT1-CD161 Interaction in Cancer: Promises and Challenges
por: Braud, Veronique M., et al.
Publicado: (2022)

Change in PD-L1 and CD8 Expression after Chemoradiotherapy for Esophageal Squamous Cell Carcinoma
por: Chen, Wei-Chung, et al.
Publicado: (2022)

BCL9 regulates CD226 and CD96 checkpoints in CD8(+) T cells to improve PD-1 response in cancer
por: Feng, Mei, et al.
Publicado: (2021)

CD133/Prominin-1-Mediated Autophagy and Glucose Uptake Beneficial for Hepatoma Cell Survival
por: Chen, Haiyang, et al.
Publicado: (2013)

Frequency of CD4+CD161+ T Cell and Interleukin-10 Expression in Inflammatory Bowel Diseases
por: Tsuchiya, Kazuyo, et al.
Publicado: (2017)

Differential Effect of Cytomegalovirus Infection with Age on the Expression of CD57, CD300a, and CD161 on T-Cell Subpopulations
por: Hassouneh, Fakhri, et al.
Publicado: (2017)

Low Levels of Peripheral CD161++CD8+ Mucosal Associated Invariant T (MAIT) Cells Are Found in HIV and HIV/TB Co-Infection
por: Wong, Emily B., et al.
Publicado: (2013)

Circulating memory PD-1(+)CD8(+) T cells and PD-1(+)CD8(+)T/PD-1(+)CD4(+)T cell ratio predict response and outcome to immunotherapy in advanced gastric cancer patients
por: Liu, Jiang, et al.
Publicado: (2023)

PD-1 and BTLA and CD8(+) T-cell “exhaustion” in cancer: “Exercising” an alternative viewpoint
por: Haymaker, Cara, et al.
Publicado: (2012)

Targeted inhibition of RBPJ transcription complex alleviates the exhaustion of CD8(+) T cells in hepatocellular carcinoma
por: Pan, Banglun, et al.
Publicado: (2023)

CD8+CD122+PD-1+ Tregs Synergize With Costimulatory Blockade of CD40/CD154, but Not B7/CD28, to Prolong Murine Allograft Survival
por: Liu, Huazhen, et al.
Publicado: (2019)

Single-cell atlas of diverse immune populations in the advanced biliary tract cancer microenvironment
por: Shi, Xuebing, et al.
Publicado: (2022)

Expansion of cytotoxic tissue-resident CD8(+) T cells and CCR6(+)CD161(+) CD4(+) T cells in the nasal mucosa following mRNA COVID-19 vaccination
por: Ssemaganda, Aloysious, et al.
Publicado: (2022)

Expansion of mixed immune cells using CD3/CD161 co-stimulation for the treatment of cancer
por: Tsumura, Ryo, et al.
Publicado: (2023)

Peripheral CD8+CD28+ T lymphocytes predict the efficacy and safety of PD-1/PD-L1 inhibitors in cancer patients
por: Geng, Ruixuan, et al.
Publicado: (2023)

Impact of Aging on the Frequency, Phenotype, and Function of CD161-Expressing T Cells
por: van der Geest, Kornelis S. M., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_eut7nl2ejbc5b9is7tp5nehclm